COPD Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for COPD trials.

Effective solutions for advancing COPD research

Over 16 million people suffer from chronic obstructive pulmonary disease (COPD) in the US alone. Although preventable and treatable, this common disease causes difficulty breathing and can progressively worsen over time. Researchers are working to develop treatments to control symptoms and improve the patient's quality of life. Signant's digital solutions help researchers monitor patients and collect high-quality evidence.

Why Signant Health

  • Build eCOA Studies Quickly
  • Capture Informed Signatures
  • Observe Real-World Behavior
  • Keep Patients Enrolled & Engaged
  • Streamline Randomization
  • Virtual Visits
  • Build eCOA Studies Quickly

    Build eCOA Studies Quickly

    Our Signant SmartSignals eCOA solution features ready-to-go questionnaires, including the SGRQ, EXACT-PRO, CAT, and the mMRC scale, measures commonly used to support inclusion criteria and endpoints. 

     

  • Capture Informed Signatures

    Capture Informed Signatures

    Signant SmartSignals eConsent uses engaging multimedia to teach study requirements to patients and caregivers. The digital solution also ensures the various consents are completed with the correct IRB- or EC-approved form. 
     

  • Observe Real-World Behavior

    Observe Real-World Behavior

    Integrate eCOA with our pulse oximeter to gain insight into changes in the patient's respiration rate and blood oxygen levels. You can also integrate our Actigraph sensors and wearables to for a comprehensive understanding of the effects of the disease and treatment on the patient's every day life.

  • Keep Patients Enrolled & Engaged

    Keep Patients Enrolled & Engaged

    Our patient engagement solution is conveniently located on the same platform as our eCOA solution, providing a single touchpoint for patients to access visit schedules, medication intake instructions, study updates, and reminders.

  • Streamline Randomization

    Streamline Randomization

    Choose Signant’s Randomization & Trial Supply Management (RTSM) solution to efficiently handle randomization and deliver medication on time to patients around the world.
     
     

  • Virtual Visits

    Virtual Visits

    Signant SmartSignals Telemedicine can replace in-person visits with convenient video consultations, reducing travel burdens for patients.

     

Comprehensive COPD experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore COPD trial optimization resources
ARTICLE

Measuring Free-Living Physical Activity in COPD Patients



GET INSIGHTS
BLOG

Optimizing COPD Management: Early Detection and Exacerbation Diaries





LEARN MORE
SOLUTION

Sensors & Wearables


 
EXPLORE FEATURES

Accelerate your COPD trial success

Discover how Signant's specialized solutions can address unique challenges in your current or upcoming COPD research.